{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-22-025893","form_type":"8-K","ticker":"BHVN","cik":"0001935979","company_name":"Biohaven Ltd.","filed_at":"2022-10-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.986597+00:00","generated_at":"2026-06-23T06:08:25.152712+00:00","sec_items":["5.01","5.02","5.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Biohaven Ltd. completes spin-off from RemainCo, appoints CFO and board","bullets":["Spin-off effective Oct 3, 2022; shareholders received 1 Biohaven share per 2 RemainCo shares; 35,832,557 shares issued.","Matthew Buten appointed CFO effective Sept 28, 2022.","Board of directors named: Class I (Antonijevic, Heffernan, Hugin), Class II (Bailey, Childs, Gregory), Class III (Coric, Mehta).","Adopted 2022 Equity Incentive Plan, Employee Share Purchase Plan, and Legacy Award Settlement Plan.","Entered transition services, US distribution (Nurtec ODT) and outsourcing agreements with RemainCo and Pfizer."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-22-025893","json":"https://secwatch.observer/filing/0001628280-22-025893.json","markdown":"https://secwatch.observer/filing/0001628280-22-025893.md","text":"https://secwatch.observer/filing/0001628280-22-025893.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1935979/000162828022025893/0001628280-22-025893-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1935979/000162828022025893/biohavenltd8-k1032022.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T06:08:25.152712+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"27281b120c","claim":"John Childs was appointed as Director at Biohaven Ltd..","evidence_excerpt":"Designated as Class II directors, with initial terms expiring at the 2024 annual meeting of Biohaven shareholders: • Gregory Bailey • John Childs","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1935979/000162828022025893/0001628280-22-025893-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"2e2bcd8c82","claim":"Gregory Bailey was appointed as Director at Biohaven Ltd..","evidence_excerpt":"Designated as Class II directors, with initial terms expiring at the 2024 annual meeting of Biohaven shareholders: • Gregory Bailey","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1935979/000162828022025893/0001628280-22-025893-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"3a2251931c","claim":"Kishan Mehta was appointed as Director at Biohaven Ltd..","evidence_excerpt":"Designated as Class III directors, with initial terms expiring at the 2025 annual meeting of Biohaven shareholders: • Vladimir Coric • Kishan Mehta","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1935979/000162828022025893/0001628280-22-025893-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"3fcac078d7","claim":"Matthew Buten was appointed as Chief Financial Officer at Biohaven Ltd..","evidence_excerpt":"On September 28, 2022, the Company appointed Matthew Buten as Chief Financial Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1935979/000162828022025893/0001628280-22-025893-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"5d85d50c75","claim":"Vladimir Coric was appointed as Director at Biohaven Ltd..","evidence_excerpt":"Designated as Class III directors, with initial terms expiring at the 2025 annual meeting of Biohaven shareholders: • Vladimir Coric • Kishan Mehta","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1935979/000162828022025893/0001628280-22-025893-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"76fb470ac7","claim":"Robert Hugin was appointed as Director at Biohaven Ltd..","evidence_excerpt":"Designated as Class I directors, with initial terms expiring at the 2023 annual meeting of Biohaven shareholders: • Irina Antonijevic • Michael T. Heffernan • Robert Hugin","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1935979/000162828022025893/0001628280-22-025893-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"8415770f61","claim":"Michael T. Heffernan was appointed as Director at Biohaven Ltd..","evidence_excerpt":"Designated as Class I directors, with initial terms expiring at the 2023 annual meeting of Biohaven shareholders: • Irina Antonijevic • Michael T. Heffernan","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1935979/000162828022025893/0001628280-22-025893-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"ec84a2e617","claim":"Julia Gregory was appointed as Director at Biohaven Ltd..","evidence_excerpt":"Designated as Class II directors, with initial terms expiring at the 2024 annual meeting of Biohaven shareholders: • Gregory Bailey • John Childs • Julia Gregory","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1935979/000162828022025893/0001628280-22-025893-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"f0b6dbd131","claim":"Irina Antonijevic was appointed as Director at Biohaven Ltd..","evidence_excerpt":"The following persons were appointed as directors of Biohaven on September 28, 2022: Designated as Class I directors, with initial terms expiring at the 2023 annual meeting of Biohaven shareholders: • Irina Antonijevic","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1935979/000162828022025893/0001628280-22-025893-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}